In contrast, BA synthesis seems to play a significant role in hepatic injury under cholestatic conditions, as suppression of hepatic BA synthesis following administration of an engineered form of FGF19 led to dramatic protection of the liver from cholestasis [14]. The gene discussed is FGF19; the disease is cholestasis.